Drug Profile


Alternative Names: Shiga-like toxin; SLT-1; VeroPulse; Verotoxin 1; VT-1

Latest Information Update: 23 Nov 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator University of Toronto Innovations Foundation
  • Class Antineoplastics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 08 Feb 2005 AlphaRx has terminated its license for verotoxin worldwide
  • 08 Feb 2005 Suspended - Preclinical for Cancer in Canada (unspecified route)
  • 08 Feb 2005 Suspended - Preclinical for Cancer in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top